| Description | Labetuzumab is a humanized anti-carcinoembryonic antigen (CEA) monoclonal antibody with anticancer activity that inhibits tumor growth and is used in the study of thyroid and colorectal cancer (CRC). |
| In vivo | 在体内，单次静脉注射Labetuzumab，剂量为每只大鼠0.5 mg，可抑制肿瘤生长[1]。 |
| Synonyms | IMMU-14, hMN-14, IMMU-100 |
| molecular weight | N/A |
| CAS | 219649-07-7 |
| Storage | store at low temperature | store at -20°C |
| References | 1. Stein R, et al. A humanized monoclonal antibody to carcinoembryonic antigen, labetuzumab, inhibits tumor growth and sensitizes human medullary thyroid cancer xenografts to dacarbazine chemotherapy. Mol Cancer Ther. 2004 Dec;3(12):1559-64. |